Chahla Jorge, Stone Jonathan, Mandelbaum Bert R
Rush University Medical Center, Chicago, Illinois, U.S.A..
Rush University Medical Center, Chicago, Illinois, U.S.A.
Arthroscopy. 2019 Oct;35(10):2771-2773. doi: 10.1016/j.arthro.2019.08.021.
Although small cartilage injuries are commonly found in knee arthroscopy procedures, significant chondral and osteochondral injuries are relatively infrequent. Incidence of cartilage injury rises when considering traumatic origin, especially when approaching significant ligamentous or meniscal pathology. Options for restoration span the gamut from benign neglect to open procedures that restore both cartilage and subchondral bone. The best choice of procedure largely depends on lesion size, depth, and location. Smaller lesions isolated to cartilage <2 cm can be treated with marrow stimulation techniques such as microfracture with or without biologic options (bone marrow aspirate concentrate or platelet-rich plasma with or without cartilage precursors or scaffolds). Microfracture alone in larger lesions has been reported to be less durable and it is therefore not recommended for larger lesions. Smaller lesions <2 cm that include a subchondral injury can be treated with osteochondral autograft implantation, in which a core of cartilage and bone is transferred from a relative non-weightbearing surface to the lesion. Larger osteochondral lesions >2 cm are better treated with osteochondral allograft transplantation, where osteochondral cores from a size-matched, fresh cadaver are matched to the patient's lesion. This option may require multiple cores to be placed in a "snowman" pattern; however, recent literature demonstrated that a single plug might produce better outcomes. Alternatively, for large chondral-only lesions, a resurfacing procedure may be chosen that may include biologic options. Autologous chondrocyte implantation (ACI), currently in its third iteration (matrix ACI [MACI]), is an excellent choice with good long-term durability. In addition, MACI may be used for chondral lesions in the patellofemoral joint where matching the native joint topology may be more difficult. If the patient has an underlying bone marrow lesion but an intact cartilage cap that appears healthy on arthroscopic examination, one may consider a core decompression and injection with biologics such as BMAC and bony scaffold with fibrin glue (also known as bioplasty). It is also critical that the surgeon address any concomitant knee pathology that would compromise cartilage restoration. This includes addressing malalignment with distal femoral, proximal tibial, or tibial tubercle osteotomy, significant meniscal deficiency with meniscal transplant, and any instability from lack of cruciate or collateral ligaments with ligament reconstruction.
尽管在膝关节镜手术中常见小的软骨损伤,但严重的软骨和骨软骨损伤相对较少见。当考虑外伤原因时,软骨损伤的发生率会升高,尤其是在存在严重韧带或半月板病变时。修复方法多种多样,从保守观察到恢复软骨和软骨下骨的开放性手术。最佳手术选择很大程度上取决于病变的大小、深度和位置。局限于软骨的较小病变(<2 cm)可采用骨髓刺激技术治疗,如微骨折,可结合或不结合生物治疗方法(骨髓抽吸浓缩物或富血小板血浆,可结合或不结合软骨前体或支架)。据报道,单独使用微骨折治疗较大病变的效果不太持久,因此不推荐用于较大病变。包括软骨下损伤的较小病变(<2 cm)可采用自体骨软骨移植植入术治疗,即将一块软骨和骨的核心从相对非负重面转移至病变处。较大的骨软骨病变(>2 cm)采用同种异体骨软骨移植术治疗效果更佳,即从大小匹配的新鲜尸体获取骨软骨核心,与患者的病变进行匹配。这种方法可能需要将多个核心以“雪人”模式放置;然而,近期文献表明,单个移植物可能会产生更好的效果。另外,对于仅为大的软骨病变,可选择包括生物治疗方法的表面修复手术。自体软骨细胞植入术(ACI),目前已发展到第三代(基质ACI [MACI]),是一种具有良好长期耐久性的极佳选择。此外,MACI可用于髌股关节的软骨病变,因为在此处匹配天然关节拓扑结构可能更困难。如果患者存在潜在的骨髓病变,但在关节镜检查中软骨帽完整且看起来健康,则可考虑进行核心减压并注射生物制剂,如骨髓抽吸浓缩物和带纤维蛋白胶的骨支架(也称为生物成形术)。外科医生处理任何可能影响软骨修复的膝关节合并病变也很关键。这包括通过股骨远端、胫骨近端或胫骨结节截骨术纠正力线不良,通过半月板移植治疗严重半月板缺损,以及通过韧带重建治疗因交叉韧带或侧副韧带缺失导致的任何不稳定。